Alendronate 70 mg Once Weekly and alendronate 10 mg Once Daily preference study in postmenopausal women with osteoporosis.

被引：0
作者：
Palmisano, J
Lewiecki, EM
Rosen, C
Bockman, RS
Vanaman, LK
Smith, M
Wang, L
Yates, J
机构：
[1] Merck & Co Inc, W Point, PA USA
[2] New Mexico Clin Res & Osteoporosis Ctr, Albuquerque, NM USA
[3] Maine Ctr Osteoporosis, Bangor, ME USA
[4] Hosp Special Surg, New York, NY 10021 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2001年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [31] COMPARING DAILY STRONTIUM RANELATE WITH ONCE WEEKLY ALENDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Galesanu, Corina
    Lisnic, Natalia
    Florescu, Alexandru
    Loghin, Andra Iulia
    Aancute, Adrian
    Zaharia, Valentin
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S88 - S88
  • [32] Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study
    Shinji Uchida
    Tadaaki Taniguchi
    Takafumi Shimizu
    Taro Kakikawa
    Kotoba Okuyama
    Masahiko Okaniwa
    Hironori Arizono
    Koichi Nagata
    Arthur C. Santora
    Masataka Shiraki
    Masao Fukunaga
    Tatsushi Tomomitsu
    Yasuo Ohashi
    Toshitaka Nakamura
    Journal of Bone and Mineral Metabolism, 2005, 23 : 382 - 388
  • [33] Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study
    Uchida, S
    Taniguchi, T
    Shimizu, T
    Kakikawa, T
    Okuyama, K
    Okaniwa, M
    Arizono, H
    Nagata, K
    Santora, AC
    Shiraki, M
    Fukunaga, M
    Tomomitsu, T
    Ohashi, Y
    Nakamura, T
    JOURNAL OF BONE AND MINERAL METABOLISM, 2005, 23 (05) : 382 - 388
  • [34] Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis (vol 20, pg 2031, 2004)
    Sebba, AI
    Bonnick, SL
    Kagan, R
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (02) : 325 - 325
  • [35] Therapeutic equivalence of alendronate (ALN) 35-mg once weekly (OW) and 5-mg daily (D) in the prevention of postmenopausal osteoporosis
    Luckey, M
    Insogna, K
    Gilchrist, N
    Bone, H
    Davie, M
    De Villiers, T
    Orloff, J
    Santora, A
    Wu, M
    Yates, J
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S209 - S209
  • [36] Efficacy, safety and tolerability of once weekly (80mg vs 160mg) oral alendronate over 2 years in postmenopausal osteoporosis.
    Brown, JP
    Banville, C
    Jean, S
    Drake, WL
    Kendler, DL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S375 - S375
  • [37] The efficacy and tolerability of once-weekly alendronate 70 mg on bone mineral density and bone turnover markers in postmenopausal Chinese women with osteoporosis
    Yan, Yuxiang
    Wang, Wei
    Zhu, Hanmin
    Li, Mei
    Liu, Jianli
    Luo, Bangyao
    Xie, Haibao
    Zhang, Guangjian
    Li, Fuobao
    JOURNAL OF BONE AND MINERAL METABOLISM, 2009, 27 (04) : 471 - 478
  • [38] Patient preference for once-monthly lbandronate compared with weekly alendronate in postmenopausal osteoporosis
    Seidman, Larry S.
    Kornowski, Anne
    Devas, Vipul
    Masanauskaite, Daiva
    Emkey, Ron
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (04) : 24S - 25S
  • [39] The efficacy and tolerability of once-weekly alendronate 70 mg on bone mineral density and bone turnover markers in postmenopausal Chinese women with osteoporosis
    Yuxiang Yan
    Wei Wang
    Hanmin Zhu
    Mei Li
    Jianli Liu
    Bangyao Luo
    Haibao Xie
    Guangjian Zhang
    Fuobao Li
    Journal of Bone and Mineral Metabolism, 2009, 27 : 471 - 478
  • [40] Patient complience and preference of alendronate once weekly administration in comparison with daily regimens for osteoporotic postmenopausal women
    Baroutsou, B
    Babiolakis, DDB
    Stamatiadou, AAS
    Andronis, CCA
    Piskontaki, IIP
    Xristogiannis, FX
    Kousta, EEK
    Athanasio, IIA
    Spanoudis, DDS
    Basilakis, R
    Voudouris, KKV
    Georgiadis, AAG
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 455 - 456
12345